Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01262222 · ClinicalTrials.gov registry record
Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 67
- Enrollment target
NCT01262222: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01262222 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 67 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01262222 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 67 participants
- Enrollment target
Study Summary
The purpose of this study is to look at a new method for finding out if patients have a risk of heart complications from surgery. At the present, to find out if patients have a risk of heart complications from surgery, look at whether the patient has heart disease, diabetes, kidney problems, and stroke. The investigators hope that this study will confirm a new, safe test to help us predict the risk of surgery.
Interventions
- OTHER endothelial function testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2010-12 |
| Est. Completion | 2018-07-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01262222
The ClinicalTrials.gov registry entry for NCT01262222 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which endothelial function testing is the first listed.
NCT01262222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01262222 about?
NCT01262222 is a clinical study titled "Patients Undergoing Major Cancer Surgery: Incidence and Predictive Value for Postoperative Cardiac Events". The purpose of this study is to look at a new method for finding out if patients have a risk of heart complications from surgery. At the present, to find out if patients have a risk of heart complications from surgery, look at whether the patient has heart disease, diabetes, kidney problems, and str...
What is the current status of trial NCT01262222?
This trial is currently completed. The enrollment target is 67 participants. The study started on 2010-12. Estimated completion is 2018-07-11.
What interventions are being tested in trial NCT01262222?
The interventions under investigation include: endothelial function testing (OTHER).
Who is sponsoring clinical trial NCT01262222?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.